Correlation Between PTC Therapeutics and Inozyme PharmaInc

Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Inozyme PharmaInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Inozyme PharmaInc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PTC Therapeutics and Inozyme PharmaInc, you can compare the effects of market volatilities on PTC Therapeutics and Inozyme PharmaInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Inozyme PharmaInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Inozyme PharmaInc.

Diversification Opportunities for PTC Therapeutics and Inozyme PharmaInc

-0.24

Correlation Coefficient

PTC Therapeutics  Inozyme PharmaInc

Very good diversification

The 3 months correlation between PTC and Inozyme is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Inozyme PharmaInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme PharmaInc and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Inozyme PharmaInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme PharmaInc has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Inozyme PharmaInc go up and down completely randomly.

Pair Corralation between PTC Therapeutics and Inozyme PharmaInc

Given the investment horizon of 90 days PTC Therapeutics is expected to generate 2.28 times more return on investment than Inozyme PharmaInc. However, PTC Therapeutics is 2.28 times more volatile than Inozyme PharmaInc. It trades about 0.13 of its potential returns per unit of risk. Inozyme PharmaInc is currently generating about 0.0 per unit of risk. If you would invest  3,214  in PTC Therapeutics on February 29, 2024 and sell it today you would earn a total of  433.00  from holding PTC Therapeutics or generate 13.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PTC Therapeutics  vs.  Inozyme PharmaInc

PTC Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Inozyme PharmaInc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inozyme PharmaInc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with PTC Therapeutics and Inozyme PharmaInc

The main advantage of trading using opposite PTC Therapeutics and Inozyme PharmaInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Inozyme PharmaInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme PharmaInc will offset losses from the drop in Inozyme PharmaInc's long position.

The idea behind PTC Therapeutics and Inozyme PharmaInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.